Edwards said sales from continuing operations for Q4 2024 rose 9% to $1.39 billion, and TAVR sales grew 6% to $1.04 billion (5% on a constant currency basis).

1. 01

   Edwards said sales from continuing operations for Q4 2024 rose 9% to $1.39 billion, and TAVR sales grew 6% to $1.04 billion (5% on a constant currency basis).

2. 02

   The company said TMTT sales for Q4 rose 88% to $105 million, and full-year sales increased 78% year over year to $352 million.

3. 03

   Edwards said its gross profit margin for Q4 was 78.9% (79.0% adjusted), below 80.2% a year earlier, and its operating profit margin was 22.6% (25.6% adjusted). The figures are from continuing operations.

4. 04

   The company reaffirmed its 2025 guidance for constant currency sales growth of 8% to 10% and adjusted EPS of $2.40 to $2.50. It said cash and cash equivalents were approximately $3.0 billion and total debt was approximately $600 million as of December 31, 2024.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.